Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans

Documenti analoghi

• The Effects of Different Administration Regimens of Berberine Hydrochloride on the Pharmacokinetics of Sirolimus in Rats
  di: Yuanxia Yang, et al.
  Pubblicazione: (2025)
• Addressing Ethnicity in the Design and Evaluation of an Educational Intervention on Interindividual Variation in Pharmacokinetics
  di: Jennifer A. Koenig, et al.
  Pubblicazione: (2025)
• Improving Population Pharmacokinetic Modelling with Artificial Patients using Generative Artificial Intelligence
  di: Verena Schöning, et al.
  Pubblicazione: (2026)
• Pharmacokinetics and Customized Dosing of Vancomycin in Adult Patients With Hematological Malignancies: Status, Challenges, and Opportunities
  di: Xiangqing Song, et al.
  Pubblicazione: (2026)
• Identification and neuroprotective properties of NA‐184, a calpain‐2 inhibitor
  di: Michel Baudry, et al.
  Pubblicazione: (2024)